Loading data
REVBNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 4.06 m USD | 3.55 m USD | 4.15 m USD | 5.38 m USD | 6.91 m USD |
| Operating profit | -9.07 m USD | -7.98 m USD | -8.66 m USD | -10.86 m USD | -11.95 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -8.9 m USD | -15.04 m USD | -120.25 k USD | -10.83 m USD | -11.99 m USD |
| Net income attributable to common shareholders | -14.87 m USD | -15.04 m USD | — | — | — |
| Basic earnings per share | -23.95 USD/share | -1,052.16 USD/share | -8.44 USD/share | -149.2 USD/share | -42.5 USD/share |
| Diluted earnings per share | -23.95 USD/share | -1,052.16 USD/share | -8.44 USD/share | -149.2 USD/share | -42.5 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.